Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T68042 |
CHF-4227
Chf4227,Chf 4227 |
Estrogen Receptor/ERR | Endocrinology/Hormones |
CHF-4227 是一种新型高效且具有选择性的雌激素受体调节剂,可降低胆固醇合低密度脂蛋白胆固醇浓度。 | |||
T33711L |
Nolomirole HCl
CHF 1035 HCl,CHF 1035,CHF1035,CHF1035 HCl,CHF-1035 HCl,CHF-1035,Nolomirole Hydrochloride |
Dopamine Receptor; Norepinephrine | GPCR/G Protein; Neuroscience |
Nolomirole HCl(CHF 1035) 是一种具有口服活性的新型选择性多巴胺激动剂,对去甲肾上腺素的释放有抑制作用,可用于研究轻度慢性心力衰竭。 | |||
T38625 |
Tanimilast
CHF-6001 |
PDE | Metabolism |
Tanimilast (CHF-6001) 是一种新型的高效选择性磷酸二酯酶 4 抑制剂,IC 50值为0.026 ± 0.006 nM。Tanimilast 具有强大的抗炎活性,适用于肺部局部用药。Tanimilast 用于研究阻塞性肺病。 | |||
T13992 |
CHF5407
SVT-47060 |
AChR | Neuroscience |
CHF5407(SVT-47060) 是一种具有有效性和选择性的毒蕈碱 M3 受体拮抗剂,可长期作用于毒蕈碱受体。CHF5407 对支气管痉挛有作用,可用于研究呼吸系统疾病。 | |||
T30876 |
CHF 2819
Ganstigmine HCl,CHF-2819,Ganstigmine hydrochloride,CHF2819 |
||
CH-5137291 is a pure AR antagonist with AR nuclear translocation inhibition activity. It suppresses castration and prevents the growth of prostate cancer cells. | |||
T30875 |
CHF 1255
CHF1255,CHF-1255 |
||
CHF 1255 is a potential drug for the treatment of heart failure. | |||
T2262 |
Itanapraced
CHF5074,CSP-1103 |
Beta Amyloid; Gamma-secretase | Neuroscience; Proteases/Proteasome; Stem Cells |
Itanapraced (CHF5074) 是新型γ-secretase 调节剂,能够降低 Aβ42 (IC50=3.6 nM) 和 Aβ40 (IC50=18.4 nM) 分泌。 | |||
T30878 |
CHF-2993
CHF 2993,5NY5Q1OUZ3,UNII-5NY5Q1OUZ3,CHF2993 |
||
CHF-2993 is a bio-active chemical. | |||
T30879 |
CHF-5022
UNII-JO8EVV007Q,CHEMBL196246,CHF5022 |
||
CHF-5022 is a nonsteroidal anti-inflammatory drug that selectively inhibits the production of beta-amyloid protein (1-42) (ABETA42). | |||
T70572 |
CHF-2060
|
||
CHF-2060 is a novel acetylcholinesterase inhibitor. | |||
T27606 |
Indantadol HCl
CHF-3381,CMP-3381,GT-3381,V-3381,CNP-3381,Indantadol |
MAO; NMDAR | Metabolism; Neuroscience |
Indantadol HCl (CHF-3381) 是一种 NMDA 拮抗剂和非选择性 MAO 抑制剂。 | |||
T30877 |
CHF-1024
UNII-HPH2L3QA2F |
||
CH-5137291 is a pure AR antagonist with AR nuclear translocation inhibition activity. It inhibits castration and prevents the growth of prostate cancer cells. | |||
T70376 |
CHF-6366
|
||
CHF-6366是一种高效的M3毒蕈碱拮抗剂和β2肾上腺素能受体激动剂,具有pKi值分别为10.4和11.4。同时,CHF-6366作为一种弱钙离子通道抑制剂,其IC50约为50μM。该化合物能够抑制豚鼠的支气管收缩,适用于慢性阻塞性肺疾病研究。 | |||
T33711 |
Nolomirole
CHF1025,CHF-1025,CHF 1025 |
||
Nolomirole is a dopamine receptor agonist that reduces symptoms of congestive heart failure caused by monoclinine. | |||
T70375 |
ZEN-2759
|
Epigenetic Reader Domain | Chromatin/Epigenetic |
ZEN-2759 是一种有效的 BET 小分子抑制剂,对 BRD4(BD1)、BRD4(BD2) 和 BRD4(BD1BD2) 有抑制作用。 | |||
T69233 | Ganstigmine | ||
Ganstigmine is an acetylcholinesterase inhibitor for Alzheimer's disease. | |||
T1461 |
Candesartan
CV 11974,坎地沙坦 |
RAAS | Endocrinology/Hormones |
Candesartan (CV 11974) 是一种血管紧张素II 受体拮抗剂(IC50:0.26 nM)。 | |||
T71937 |
Nitrodenafil
|
||
Nitrodenafil is a related compound of Sildenafil -- a phosphodiesterase inhibitor. | |||
T5329 |
Trandolapril
|
Angiotensin-converting Enzyme (ACE) | Metabolism |
Trandolapril 是 Trandolaprilat 的前体药物。Trandolapril 是一种口服血管紧张素转换酶抑制剂,在高血压和充血性心力衰竭及心肌梗死领域有研究价值。 | |||
T71944 |
FGF/PDGF/VEGF RTK Inhibitor
|
||
FGF/PDGF/VEGF RTK Inhibitor is a potent, reversible, atp-competitive inhibitor against pdgfrβ, fgfr-1, and vegfr-2 (ic50 = 20, 90, and 240 nm, respectively) and effectively suppresses vegf-stimulated proliferation of hmvecs (ec50 = 420 nm). | |||
T70638 |
p38-α MAPK-IN-5
|
||
p38-α MAPK-IN-5 是一种有效的 p38α抑制剂,对 p38α、p38 β、p38γ、p38δ 的 IC50分别为 0.1 nM、0.2 nM、944 nM、4100 nM。p38-α MAPK-IN-5 具有抗炎作用,并且具有用于哮喘和慢性阻塞性肺病 (COPD) 研究的潜力。 | |||
T18720 | FCHFHS-ST7612AA1 | Others | Others |
FCHFHS-ST7612AA1 is a part of antibody drug conjugates (ADCs) charged with HDAC inhibitor by a linker, shows antitumor activity[1]. | |||
T13195 |
Trandolapril D5
RU44570 D5 |
Others | Others |
Trandolapril D5 is a deuterium labeled Trandolapril. Trandolapril is an orally active inhibitor of angiotensin converting enzyme (ACE) for hypertension and congestive heart failure (CHF). | |||
T30501 |
BMS-193884
BMS193884,BMS 193884 |
||
BMS-193884 is an oral endothelin antagonist for the treatment of congestive heart failure (CHF) and pulmonary arterial hypertension. | |||
T36008 |
Nebentan potassium
|
||
Nebentan potassium (YM598) is a potent, selective and orally active non-peptide endothelin ETA receptor antagonist through the modification of Bosentan . Nebentan potassium inhibits [125I] endothelin-1 binding to cloned human endothelin ETA and ETB receptor, with Ki of 0.697 nM and 569 nM, respectively[1]. YM598 can ameliorate the progression of cor pulmonale and myocardial infarction in vivo[2]. Nebentan potassium inhibits the specific binding of [125I] endothelin-1 to endothelin ETA and ETB re... | |||
T71065 |
Quinapril-d5
|
||
Quinapril-d5 is intended for use as an internal standard for the quantification of quinapril by GC- or LC-MS. Quinapril is a prodrug form of the angiotensin converting enzyme (ACE) inhibitor quinaprilat. In vivo, quinapril reduces mean arterial pressure in renal hypertensive and spontaneously hypertensive rats. It inhibits angiotensin I-induced pressor responses in normotensive rats and dogs. Quinapril prevents left ventricular heart failure in CHF 14.6 cardiomyopathic hamsters. Formulations con... | |||
T36007 |
Nebentan
|
||
Nebentan (YM598) is a potent, selective and orally active non-peptide endothelin ETA receptor antagonist through the modification of Bosentan . Nebentan inhibits [125I] endothelin-1 binding to cloned human endothelin ETA and ETB receptor, with Ki of 0.697 nM and 569 nM, respectively[1]. YM598 can ameliorate the progression of cor pulmonale and myocardial infarction in vivo[2]. Nebentan inhibits the specific binding of [125I] endothelin-1 to endothelin ETA and ETB receptors in a concentration dep... |